PillRx only · Tablet · Oral
Ultramicrosize Griseofulvin
Griseofulvin
3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US4 NDCs
3 active makers
3 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$3.436
Latest avg · Jul 22, 2026
+3%
Since Jul 23, 2025
3
Active US suppliers
75%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
48
Rx · 2026 Q1
2.3K
Units dispensed
-71%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it3 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| SIGMAPHARM LABORATORIES, LLC | unknown | 2 | SUPPLYING |
| Chartwell RX, LLC | unknown | 1 | SUPPLYING |
| Ayurax, LLC | unknown | 1 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.